Most insurance plans, including Medicare, cover vein treatment when it’s deemed medically necessary. The key distinction is whether your veins are causing symptoms or complications versus being a purely cosmetic concern. Asymptomatic veins treated for appearance alone are classified as cosmetic and denied coverage. If your veins cause pain, swelling, skin changes, or other documented symptoms, you have a strong chance of getting coverage, but you’ll need to clear several hurdles first.
What “Medically Necessary” Means for Vein Treatment
Insurance companies draw a hard line between cosmetic and medical vein procedures. Medicare’s coverage policy states it plainly: treatment of asymptomatic veins with ablation or sclerotherapy is not considered medically reasonable and necessary, and claims will be denied as cosmetic if veins are found to be asymptomatic on review.
To qualify as medically necessary, your vein condition typically needs to meet three criteria. First, you must have documented symptoms: pain, aching, heaviness, swelling, skin discoloration, bleeding, or ulcers in the affected leg. Second, you’ll need a diagnostic ultrasound showing that blood is flowing backward in the vein (called venous reflux), confirming the underlying problem. Insurance generally covers one pre-procedure ultrasound to establish this diagnosis. Third, and this is where many patients get stuck, you must complete a trial of conservative therapy before your insurer will approve a procedure.
The Compression Stocking Requirement
Nearly all insurers require you to wear prescription compression stockings for a set period before they’ll authorize surgery or ablation. The typical mandate is around three months, though the exact duration varies by plan. This is meant to show that simpler measures didn’t resolve your symptoms.
Whether this requirement actually helps patients is debatable. A study of 200 patients referred for vein treatment found that among those who faithfully wore compression stockings as prescribed, only 1 out of 64 chose to stick with stockings instead of proceeding to a corrective procedure. The average stocking trial lasted 103 days. In other words, the mandated waiting period delayed treatment for the vast majority of patients without changing the outcome. Still, skipping this step or failing to document it will almost certainly result in a denied claim, so it’s worth taking seriously. Keep a log of your stocking use, and report any persistent symptoms to your doctor during follow-up visits so there’s a paper trail.
Which Procedures Are Covered
When your treatment does qualify as medically necessary, most major insurers cover a broad range of modern vein procedures. Aetna’s policy, which is representative of what you’ll find across large insurers, lists the following as covered options:
- Endovenous laser therapy (EVLT): uses targeted heat from a laser fiber to seal a damaged vein shut
- Radiofrequency ablation (RFA): similar to laser therapy but uses radiofrequency energy instead
- Sclerotherapy (liquid or foam): a chemical solution injected into the vein to close it, covered when treating veins linked to venous insufficiency
- Ambulatory phlebectomy: removal of bulging surface veins through tiny incisions
- Vein stripping and ligation: surgical removal of the affected vein, reserved for severe cases where less invasive options aren’t suitable
These procedures are all outpatient, meaning you go home the same day. EVLT and RFA have largely replaced traditional vein stripping as the standard approach. Medicare also covers phlebectomy performed on the same day as an ablation procedure, and sclerotherapy used alongside ablation, as long as each meets the medical necessity criteria independently.
Spider Veins Are Treated Differently
Spider veins, those small red or purple webs visible just under the skin, are almost never covered by insurance on their own. They’re considered a cosmetic issue unless they’re caused by an underlying vein disease like chronic venous insufficiency. If your doctor can demonstrate with ultrasound that your spider veins stem from a deeper circulation problem, sclerotherapy to treat them may be partially or fully covered. Without that documented connection, you’re paying out of pocket.
The cost for cosmetic spider vein sclerotherapy averages about $500 per session, according to the American Society of Plastic Surgeons, though that figure doesn’t include facility fees or any additional sessions you might need. Most people require multiple sessions, so the total can climb quickly.
What Vein Treatment Costs Without Insurance
If your treatment is classified as cosmetic or you don’t have insurance, the financial picture changes significantly. Spider vein sclerotherapy runs $300 to $500 per session. Larger procedures like EVLT and radiofrequency ablation are considerably more expensive, often ranging from $1,500 to $3,000 per leg depending on the complexity and your geographic area. Vein stripping, which involves anesthesia and a more involved recovery, typically costs more than minimally invasive alternatives.
Even with insurance approval, you’ll still be responsible for your plan’s copay, deductible, and coinsurance. Since vein treatment is often done in stages (treating one leg at a time, or addressing the main trunk vein before smaller branches), costs can accumulate across multiple visits. Ask your provider’s billing office for a pre-authorization breakdown before scheduling so you know your share upfront.
How to Improve Your Chances of Approval
The approval process follows a predictable path, and knowing the steps gives you an advantage. Start with a consultation at a vein clinic, where you’ll get a diagnostic ultrasound. This scan needs to show measurable reflux in your veins, meaning blood is pooling instead of flowing back toward the heart. Your doctor will document your symptoms in detail at this visit.
Next, your doctor will prescribe compression stockings, typically 20 to 30 mmHg or higher. Wear them consistently for the full period your insurer requires, usually 8 to 12 weeks, and attend any follow-up appointments so your provider can note that symptoms persist despite conservative therapy. This documentation is what your insurer reviews when deciding whether to authorize a procedure.
Once the conservative therapy trial is complete and your symptoms haven’t resolved, your doctor’s office submits a prior authorization request. This includes your ultrasound results, symptom documentation, and proof of the compression stocking trial. If your initial request is denied, ask your provider to file an appeal. Denials are sometimes reversed when additional clinical documentation is provided, particularly if your symptoms have worsened or you’ve developed complications like skin changes or ulceration.
Coverage policies are updated periodically. Medicare’s current varicose vein policy was most recently reviewed in mid-2025. Private insurers revise their own policies on similar timelines, so if you were denied in the past, it may be worth checking whether your plan’s criteria have changed.